Principal Securities »

Amicus Therapeutics shares owned by Principal Securities

Quarter-by-quarter ownership of Amicus Therapeutics (FOLD) shares owned by Principal Securities from 13F filings

Historical chart of Principal Securities investment in Amicus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Amicus Therapeutics held by Principal Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amicus Therapeutics by Principal Securities

Quarter filed Position value Share count Share price at filing
2024-03-31 $7.0k 594 11.78
2023-12-31 $6.6k 464 14.19

More positions owned by Principal Securities

Principal Exchange Traded Us Mega Cp Etf (USMC)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Core Us Aggbd Et (AGG)
Goldman Sachs Etf Tr Marketbeta Us Eq (GSUS)
Microsoft Corporation (MSFT)
Ishares Tr Rus 1000 Etf (IWB)
Amazon (AMZN)
Principal Exchange Traded Prnc Invt Grad (IG)
Goldman Sachs Etf Tr Activebeta Int (GSIE)
Spdr Ser Tr Portfolio S&p500 (SPLG)
Principal Exchange Traded Prncpl Vlu Etf (PY)
Goldman Sachs Etf Tr Access Us Agrat (GCOR)
Vanguard Index Fds Total Stk Mkt (VTI)
Apple (AAPL)

View all positions for Principal Securities

Top funds holding Amicus Therapeutics

Vanguard Group
Perceptive Advisors
venBio Select Advisor
BlackRock
Jpmorgan Chase & Co
Wellington Management Company
Redmile Group
William Blair Investment Management
Henderson Group
Palo Alto Investors
Pictet Asset Management Holding SA
Geode Capital Management
Deutsche Bank Aktiengesellschaft
Fiera Capital Corporation
American Century Companies

View all funds holding Amicus Therapeutics